Clinical Trial Update: Safety Study of CTX-100 Inhalation Solution (Formerly ETX-100) [Phase 2]

View source ↗

Summary

Phase 2 safety study update for CTX-100 inhalation solution (formerly ETX-100) in COPD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• CTX-100 inhalation solution (CTX-100 inhalation solution)

Snippet

Sponsor: Turino, Gerard, M.D. | Conditions: Chronic Obstructive Pulmonary Disease (COPD) | Phase 2 | Status: COMPLETED